Abattis Bioceuticals (ATTBF) is a Canadian company focusing on the biotechnology, licensing, cultivation, and distribution of cannabis products. Aiming to be a player in the marijuana markets in Canada and the US, the company operates through subsidiaries and with partners in the industry.
Incorporated in 1997, Abattis Bioceuticals was formerly known as Abattis Biologix Corp until it changed to its current name in 2012. It is now traded in OTC markets as ATTBF, having a market cap of USD 14.55 M.
There are five featured subsidiaries of the company: Biocube Green Grow Systems Corp; Biocell Labs, Inc; iJuana Cannabis, Inc; North America Bioextracts; and Northern Vine Canada, Inc.
Biocube Green Grow Systems Corp is a provider of controlled cultivation environments. One of its primary products is the MgO board, a building material with many benefits and to which Biocube owns exclusive rights.
Biocell Labs, Inc is the Abattis subsidiary that supplies proprietary cannabis formulations for pharmaceutical, nutraceutical, and cosmetic products.
IJuana Cannabis, Inc. meanwhile grows cannabis in a 27,000-square foot facility in Squamish, BC. It will also serve as the company’s end-consumer representative.
North America Bioextracts, which has offices in Washington State and Canada, develops and retails end-user cannabis products such as extract oils and vaporizer flavors.
Finally, Northern Vine Canada, Inc processes, tests, and packages marijuana, as well as provides analytical services, in the company’s Langley, BC facility.
Abattis Bioceuticals’ partners include the testing firm PhytaLab, the cannabis strain developer Experion Bio Technologies, Inc, and the transactions technology provider Instant Payment Systems.
The top management team at Abattis is comprised of Michael Withrow, Chairman, CEO, and President; Rene David, CFO and COO; Jason Anderson, VP of Finance; and Gilbert G. Schneider, Consultant.